Table 1 Demographic, clinical and biochemical characteristics of patients with HCV
HCV patients (n = 365) | |
|---|---|
% (n) or mean ± SD | |
Age (years) | 54.54 ± 12.7 |
Men /Women (n) | 44.9% (164) / 55.1% (201) |
Race (n) | |
White | 76.7% (280) |
Multiracial (Brown) | 13.8% (51) |
Black | 9.3% (34) |
Type 2 diabetes (n) | 23.1% (83/359) |
Dyslipidemia (n) | 20.1% (72/358) |
High-blood pressure (n) | 43.5% (156/359) |
Obesity (BMI ≥ 30) | 29.4% (106/360) |
BMI | 27.57 ± 5.02 |
Metabolic Syndrome (n) | 23.2% (83/358) |
Hypothyroidism (n) | 17.3% (62/359) |
Previous alcohol use (n) | 8.4% (30/359) |
Previous CVE (n) | 5.0% (17/359) |
HCV genotype (n) | |
1 | 79.4% (289/364) |
2 | 2.2% (8/364) |
3 | 17.9% (65/364) |
4 | 0.5% (2/364) |
HOMA-IR | 3.18 ± 4.24 |
AST (U/L) | 63.36 ± 50.84 |
ALT (U/L) | 68.84 ± 51.27 |
Alkaline phosphatase (U/L) | 83 ± 34.62 |
GGT (U/L) | 102.07 ± 110.32 |
Creatinine (mg/dL) | 0.89 ± 0.6 |
Total cholesterol (mg/dL) | 157.25 ± 36.06 |
HDL (mg/dL) | 52.11 ± 16.31 |
LDL (mg/dL) | 85.01 ± 31.22 |
Triglycerides (mg/dL) | 101.81 ± 52.5 |
Liver histology | |
Fibrosis (n = 364) | |
F0 | 7.4% (27) |
F1 | 28.0% (102) |
F2 | 18.1% (66) |
F3 | 15.9% (58) |
F4 | 30.5% (111) |
Inflammation (n = 300) | |
A0 | 5.7% (17) |
A1 | 40.3% (121) |
A2 | 36.7% (110) |
A3 | 17.3% (52) |
Steatosis (n = 354) | |
0 | 44.9% (159) |
1 | 32.5% (115) |
2 | 16.7% (59) |
3 | 5.9% (21) |